| Accession Number | 0001672659-26-000011 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 14, 2026 |
| Document Date | Feb 12, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 12, 2026 | Exercise/Conversion | 6,349 | $1.08 | $6,856.92 | 56,786 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 12, 2026 | Sale | 5,828 | $28.94 | $168,634.93 | 50,958 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 12, 2026 | Sale | 521 | $29.64 | $15,441.76 | 50,437 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 13, 2026 | Exercise/Conversion | 3,541 | $10.20 | $36,118.20 | 53,978 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 13, 2026 | Sale | 3,541 | $27.33 | $96,775.53 | 50,437 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 13, 2026 | Exercise/Conversion | 4,166 | $14.25 | $59,365.50 | 54,603 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 13, 2026 | Sale | 4,166 | $27.33 | $113,856.78 | 50,437 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 13, 2026 | Sale | 6,348 | $27.58 | $175,100.06 | 44,089 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Feb 12, 2026 | Exercise/Conversion | 6,349 | $0.00 | $0.00 | 31,743 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Feb 13, 2026 | Exercise/Conversion | 3,541 | $0.00 | $0.00 | 127,501 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Feb 13, 2026 | Exercise/Conversion | 4,166 | $0.00 | $0.00 | 100,001 | Direct | โ | View Details |